Resources for Neuropharmacists

All
  • All
  • Audit and Project Information
  • Brain Health
  • Collaborating with industry partners
  • DMTS
  • Job description for team members
  • Medication
  • Population health
  • Pregnancy
  • Protocols and pathways
  • recent publications
  • Service Development
  • TMS For All Summit 2023

TMS4All Summit 2023 Report

By Joela Mathews | May 16, 2024
2023 01 Summary of the NHSE commissioning criteria for MS DMTs (3) (1)

Summary of the NHSE commissioning criteria for MS DMTs (Blueteq criteria)

By Sian McKay | December 11, 2023

Transforming MS for all (TMS4A) Projects – Sept 2021

By Transforming MS For All | August 7, 2023

ECTRIMS 2022 Abstract – TMSFA Addressing the MS Care Paradox – Practical Solutions

By Transforming MS For All | August 7, 2023
Teriflunomide protocol - Cambridge - November 2021

Teriflunomide protocol Cambridge November 2021

By Transforming MS For All | August 7, 2023

Siponimod protocol Cambridge February 2022

By Transforming MS For All | August 7, 2023

Ponesimod protocol Cambridge August 2022

By Transforming MS For All | August 7, 2023

Ofatumumab protocol Cambridge November 2021

By Transforming MS For All | August 7, 2023

Ocrelizumab protocol Cambridge November 2021

By Transforming MS For All | August 7, 2023

Natalizumab protocol Cambridge November 2021

By Transforming MS For All | August 7, 2023